 | • レポートコード：B-MOR-08586 • 出版社/出版日：Mordor Intelligence / 2018年5月1日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・製薬 |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、局所ドラッグデリバリーの世界市場について調べ、局所ドラッグデリバリーの世界規模、市場動向、市場環境、投与経路別（経皮、経眼、経鼻、経口、膣、その他）分析、製品別（製剤、装置）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・局所ドラッグデリバリーの世界市場インサイト ・局所ドラッグデリバリーの世界市場環境 ・局所ドラッグデリバリーの世界市場動向 ・局所ドラッグデリバリーの世界市場規模 ・局所ドラッグデリバリーの世界市場規模：投与経路別（経皮、経眼、経鼻、経口、膣、その他） ・局所ドラッグデリバリーの世界市場規模：製品別（製剤、装置） ・局所ドラッグデリバリーの世界市場：地域別市場規模・分析 ・局所ドラッグデリバリーの北米市場規模・予測 ・局所ドラッグデリバリーのアメリカ市場規模・予測 ・局所ドラッグデリバリーのヨーロッパ市場規模・予測 ・局所ドラッグデリバリーのアジア市場規模・予測 ・局所ドラッグデリバリーの日本市場規模・予測 ・局所ドラッグデリバリーの中国市場規模・予測 ・局所ドラッグデリバリーのインド市場規模・予測 ・局所ドラッグデリバリーの韓国市場規模・予測 ・関連企業情報・競争状況 |
The Topical Drug Delivery Market is expected to witness a CAGR of 9.5%, during the forecast period. North America has been accounted for the highest market share as compared to the other regions.
High Prevalence of Skin Diseases
The prevalence of skin infections, like eczema, psoriasis, etc. and minor ailments, like acne are increasing and having a big impact on the market globally. Psoriasis affect is observed in people of all ages, and in all countries. The reported prevalence of psoriasis in countries ranges between 0.09% and 11.43%, making psoriasis a serious global problem with at least 100 million individuals getting affected worldwide. Around 7.5 million US people are getting affected according to the American Academy of Dermatology (AAD). Hence, these statistics shows that the skin diseases prevalence is increasing at a faster pace, which is likely to impact positively on the growth of topical drug delivery market.
The other factor that drives the market includes the ease of drug delivery, approval of new drugs and technological advances and innovations.
High Frequency of Product Recalls
In 2017, Philips recalled many of products such as Tetrastem, Diabecline, Tetracycline-ABC, VenomX, Acneen, StaphWash, StringMed, NoPain, and LidoMed. These all products were being recalled after an FDA inspection as they found significant manufacturing practices that calls into question the safety, identity, strength, quality, and purity of unexpired drug products made by the firm during the past three years. This has an impact on the safety and efficacy of the product posing a risk to the patients. Also, this has posed a negative impact on the sales of the topical drug delivery devices, which is likely to restrain the growth of the market in the coming years.
The other factor, which is also restraining the market, is the regulatory scenario and pricing pressure.
North America is expected to dominate the Market
North America has been accounted for the highest share in the market due to the presence of large number of pharmaceutical companies and drug delivery technology providers. On the other hand Asia Pacific is also likely to register a healthy growth rate in the coming future. The increasing geriatric population and the rising disposable income are few of the factors, which are expected to accelerate the growth of the Asia Pacific market in the coming years.
Key Developments in the Market
• February 2018 – ValeantPharmaceuticals has entered into a licensing agreement with the Kaken Pharmaceutical Co., Ltd., to develop and commercialize new chemical entity, KP-470 for Psoriasis
Major players- GLAXOSMITHKLINE, GALDERMA, BAYER, VALEANT PHARMACEUTICALS, NOVARTIS, MEDPHARM AND HISAMITSU PHARMACEUTICALS, amongst others.
Reasons to Purchase this Report
• Current and future topical drug delivery market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Ease of Drug Delivery
6.1.2 Approval of New Drugs
6.1.3 High Prevalence of Skin Diseases
6.1.4 Technological Advances and Innovations
6.2 Market Restraints
6.2.1 Regulatory Scenario and Pricing Pressure
6.2.2 High Frequency of Product Recalls
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Route of Administration
7.1.1 Dermal
7.1.2 Ophthalmic
7.1.3 Nasal
7.1.4 Oral Topical
7.1.5 Vaginal
7.1.6 Others
7.2 By Product
7.2.1 Formulation
7.2.1.1 Solid
7.2.1.2 Semi-Solid
7.2.1.2.1 Cream & Lotion
7.2.1.2.2 Ointment
7.2.1.2.3 Gel
7.2.1.3 Liquid
7.2.1.3.1 Solution
7.2.1.3.2 Suspension
7.2.2 Device
7.2.2.1 Inhaler
7.2.2.2 Patch
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia & New Zealand
7.3.3.5 South Korea
7.3.3.6 Rest of Asia-Pacific
7.3.4 Middle East & Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of the Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Bayer
9.2 Galderma
9.3 Glaxosmithkline
9.4 Hisamitsu Pharmaceuticals
9.5 Medpharm
9.6 Novartis
9.7 Valeant Pharmaceuticals
9.8 List Not Exhaustive
10. Future of the Market